Swiss stocks - Factors to watch on Aug 6

Basler Kantonalbank

06/08/2020 07:02

ZURICH/BERLIN, Aug 6 (Reuters) - The Swiss blue-chip SMI
 .SSMI  was seen opening 0.1% lower at 10,089 points on
Thursday, according to premarket indications by bank Julius Baer
 JBPRE01 .
    Here are some of the main factors that may affect Swiss
stocks:
    
    ADECCO  ADEN.S  
    The staffing company generated a surprise second-quarter
profit even as its revenues fell by more than a quarter as the
coronavirus pandemic hit hiring around the world.
 ID:nL8N2F80QR 
    Shares indicated up 2.3%
    
    RELIEF THERAPEUTICS  RLFB.S  
    The U.S. Food and Drug Administration has granted NeuroRx
Inc Investigational New Drug (IND) permission to test RLF-100
(aviptadil) for inhaled use in patients with moderate and severe
COVID-19 to prevent progression to respiratory failure, it and
partner Relief Therapeutics Holdings said. The clinical trial of
the inhaled formulation of RLF-100 is expected to begin on or
before Sept. 1, a joint statement said.  urn:newsml:reuters.com:*:nPreMLNlba
    
    COMPANY STATEMENTS
    * Novartis  NOVN.S  said there were positive results from
studies evaluating ofatumumab (OMB157) injections versus
teriflunomide tablets in adults with relapsing forms of multiple
sclerosis.  urn:newsml:reuters.com:*:nGNEcb427g
    * Novartis says receives EC approval for new Xolair
indication to treat severe chronic rhinosinusitis with nasal
polyps {nS8N2EZ0CF]
    * VAT Group AG  VACN.S : group net sales up 28% versus Q2
2019; expects FY 2020 net sales, EBITDA, EBITDA margin and net
income to be substantially above 2019  urn:newsml:reuters.com:*:nFWN2F71WG
    * Orascom Development  ODHN.S  announced it is selling a
land plot in Egypt's El Gouna for 6.4 million Swiss francs.
 urn:newsml:reuters.com:*:nEQbZdtBya
    * Basler Kantonalbank  BSKP.S : at CHF 50.9 million, H1 net
profit was 6.5% lower than in the previous year  urn:newsml:reuters.com:*:nFWN2F71WF
    * Valiant Holding AG  VATN.S : after six months, Valiant
posted a consolidated profit of CHF 60.1 million, which is only
slightly below the previous year's result  urn:newsml:reuters.com:*:nFWN2F721F
    * Vifor Pharma AG  VIFN.S : H1 net sales of CHF 922.5
million, up 1.0% (or 4.3% in local currency)  urn:newsml:reuters.com:*:nFWN2F721B
    * Obseva SA  OBSN.S  Q2 net loss $18.2 mln $34.8 mln loss yr
ago  urn:newsml:reuters.com:*:nASN000AEZ
    
    ANALYSTS' VIEWS
    CREDIT SUISSE GROUP AG  CSGN.S : DEUTSCHE BANK RAISES TARGET
PRICE TO CHF 12 FROM CHF 11
    BELIMO HOLDING AG  BEAN.S : BERENBERG RAISES TARGET PRICE TO
CHF 8000 FROM CHF 7750
    SUNRISE COMMUNICATIONS GROUP AG  SRCG.S : BERENBERG RAISES
TARGET PRICE TO CHF 110 FROM CHF 87
    DUFRY  DUFN.S  - CREDIT SUISSE CUTS TARGET PRICE TO CHF
27.50 FROM CHF 29
    
    ECONOMY
    No major Swiss economic data scheduled

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))